Rapid Elaboration of Fragments into Leads by X-ray Crystallographic Screening of Parallel Chemical Libraries (REFiL X ).
Bentley, M.R., Ilyichova, O.V., Wang, G., Williams, M.L., Sharma, G., Alwan, W.S., Whitehouse, R.L., Mohanty, B., Scammells, P.J., Heras, B., Martin, J.L., Totsika, M., Capuano, B., Doak, B.C., Scanlon, M.J.(2020) J Med Chem 63: 6863-6875
- PubMed: 32529824 
- DOI: https://doi.org/10.1021/acs.jmedchem.0c00111
- Primary Citation of Related Structures:  
5QKC, 5QKD, 5QKE, 5QKF, 5QKG, 5QKH, 5QKI, 5QKJ, 5QKK, 5QKL, 5QKM, 5QKN, 5QKO, 5QKP, 5QKQ, 5QKR, 5QKS, 5QKT, 5QKU, 5QKV, 5QKW, 5QKX, 5QKY, 5QKZ, 5QL0, 5QL1, 5QL2, 5QL3, 5QL4, 5QL5, 5QL6, 5QL7, 5QL8, 5QL9, 5QLA, 5QLB, 5QLC, 5QLD, 5QLE, 5QLF, 5QLG, 5QLH, 5QLI, 5QLJ, 5QLK, 5QLL, 5QLM, 5QLN, 5QLO, 5QLP - PubMed Abstract: 
A bottleneck in fragment-based lead development is the lack of systematic approaches to elaborate the initial fragment hits, which usually bind with low affinity to their target. Herein, we describe an analysis using X-ray crystallography of a diverse library of compounds prepared using microscale parallel synthesis. This approach yielded an 8-fold increase in affinity and detailed structural information for the resulting complex, providing an efficient and broadly applicable approach to early fragment development.
Organizational Affiliation: 
Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.